Interestingly, patients experiencing a long duration of AD (5–7 years) showed a reduced expression of NP65 compared to AD patients with a short duration (≤4 years), but had no difference compared with controls (Ilic et al., 2019). This evidence concerns the gene NPTN and Alzheimer disease.